Loading...
Loading...
ASPI| Name | Value |
|---|---|
| Revenues | 1.2M |
| Cost of Revenue | 0.6M |
| Gross Profit | 0.6M |
| Operating Expense | 12.5M |
| Operating I/L | -12.0M |
| Other Income/Expense | -63.1M |
| Interest Income | 0.9M |
| Pretax | -75.1M |
| Income Tax Expense | 0.1M |
| Net Income/Loss | -75.1M |
ASP Isotopes Inc. is a pre-commercial stage advanced materials company specializing in the production, distribution, marketing, and sale of isotopes. The company's product portfolio includes Molybdenum-100, a non-radioactive isotope used in the medical industry, Carbon-14, and Silicon-28. Additionally, ASP Isotopes Inc. offers Uranium-235, an isotope of uranium catering to the carbon-free energy industry. By developing and supplying these isotopes, the company generates revenue through their sale to various industries, including medical and energy sectors.
